Author
B. Correia
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2018-2024 · peak 3/yrCo-Author Collaboration Network
10 top collaborators · 42 mutual co-author links7 papers
Recent·Most cited
Rational design of chemically controlled antibodies and protein therapeutics
A. Marchand, L. Bonati, S. Shui, L. Scheller, P. Gainza, S. Rosset, S. Georgeon, L. Tang, B. Correia
This study designs and tests small molecule-controlled switchable protein therapeutics by optimizing protein interactions and demonstrating in vitro and in vivo controllability with Venetoclax.
bioRxiv · Dec 22, 2022 · PreprintBioengineering
A rational blueprint for the design of chemically-controlled protein switches
S. Shui, P. Gainza, L. Scheller, C. Yang, Y. Kurumida, S. Georgeon, S. Rosset, B. Correia
This paper presents a computational strategy to design chemically-controlled protein switches using drug-inhibited interactions, expanding chemical space for synthetic circuits in mammalian cells.
bioRxiv · Jan 21, 2021Biochemistry
Immune response to vaccine candidates based on different types of nanoscaffolded RBD domain of the SARS-CoV-2 spike protein
D. Lainscek, T. Fink, V. Forstneric, I. Hafner-Bratkovic, S. Orehek, Z. Strmsek, M. Mancek Keber, P. Pecan, H. Esih, S. Malensek, J. Aupic, P. Dekleva, T. Plaper, S. Vidmar, L. Kadunc, , R. Jerala
This study evaluates DNA vaccines with RBD domains scaffolded by different peptides, finding that the β-annulus scaffold elicits the strongest immune response in mice.
bioRxiv · Aug 28, 2020 · PreprintImmunology
A bottom-up approach for the de novo design of functional proteins
C. Yang, F. Sesterhenn, J. Bonet, E. v. Aalen, L. Scheller, L. Abriata, J. Cramer, X. Wen, S. Rosset, S. Georgeon, T. S. Jardetzky, T. Krey, M. Fussenegger, M. Merkx, B. Correia
This paper introduces a bottom-up method for designing functional proteins tailored to complex motifs, demonstrating their use as biosensors and signaling ligands.
bioRxiv · Mar 11, 2020 · PreprintBioengineering
De novo protein design enables precise induction of functional antibodies in vivo
F. Sesterhenn, C. Yang, J. Cramer, J. Bonet, X. Wen, L. Abriata, I. Kucharska, C.-I. Chiang, Y. Wang, G. Castoro, S. Vollers, M. Galloux, R. Charles-Adrien, E. Dheilly, S. Rosset, , B. Correia
This paper introduces a de novo protein design algorithm called TopoBuilder that generates immunogens inducing precise antibody responses against respiratory syncytial virus in mice and non-human primates.
bioRxiv · Feb 14, 2020 · PreprintBioengineering
Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogen
F. Sesterhenn, M. Galloux, S. S. Vollers, L. Csepregi, C. Yang, D. Descamps, J. Bonet, S. Friedensohn, P. Gainza, P. Corthesy, M. Chen, S. Rosset, M.-A. Rameix-Welti, J.-F. Eleouet, S. T. Reddy, , B. Correia
This study demonstrates that a computationally designed epitope-focused immunogen enhances subdominant neutralizing antibody responses against RSV.
bioRxiv · Nov 22, 2018Immunology